Monsanto Company (MON) Shares Sold by Wells Fargo & Company MN

Wells Fargo & Company MN decreased its holdings in Monsanto Company (NYSE:MON) by 10.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 765,646 shares of the basic materials company’s stock after selling 89,642 shares during the quarter. Wells Fargo & Company MN owned about 0.17% of Monsanto worth $91,740,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in MON. OZ Management LP purchased a new stake in Monsanto in the 2nd quarter valued at $242,786,000. BlackRock Inc. raised its position in Monsanto by 6.5% in the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock valued at $3,302,038,000 after purchasing an additional 1,705,439 shares during the last quarter. Janus Henderson Group PLC raised its position in Monsanto by 2,540.4% in the 2nd quarter. Janus Henderson Group PLC now owns 1,491,324 shares of the basic materials company’s stock valued at $176,515,000 after purchasing an additional 1,434,844 shares during the last quarter. PSquared Asset Management AG raised its position in Monsanto by 239.0% in the 2nd quarter. PSquared Asset Management AG now owns 1,274,320 shares of the basic materials company’s stock valued at $150,829,000 after purchasing an additional 898,395 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in Monsanto by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock valued at $3,636,697,000 after purchasing an additional 784,418 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

A number of equities analysts have commented on the stock. Royal Bank Of Canada restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Wells Fargo & Company upped their price objective on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. Barclays restated an “equal weight” rating and set a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Finally, Macquarie downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $124.61.

In related news, EVP Steven Mizell sold 11,526 shares of the stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Insiders sold a total of 49,236 shares of company stock valued at $5,931,934 in the last quarter. Insiders own 0.79% of the company’s stock.

Shares of Monsanto Company (NYSE:MON) traded up $0.03 on Wednesday, hitting $118.29. 621,897 shares of the stock were exchanged, compared to its average volume of 1,962,239. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83. The stock has a market cap of $52,212.13, a P/E ratio of 21.45, a PEG ratio of 1.71 and a beta of 1.04. Monsanto Company has a 1-year low of $104.08 and a 1-year high of $122.79.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.61. The business had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business’s revenue was up 4.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.07 EPS. equities analysts forecast that Monsanto Company will post 5.74 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be issued a $0.54 dividend. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.83%. Monsanto’s dividend payout ratio is presently 42.27%.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.chaffeybreeze.com/2017/12/06/monsanto-company-mon-shares-sold-by-wells-fargo-company-mn.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply